Is TMAO the Missing Link in Heart Disease? New Study Highlights Cellular Stress
"Research uncovers how TMAO, a gut-related compound, may trigger stress in immune cells, potentially worsening atherosclerosis."
Heart disease remains a leading cause of death worldwide, driven by factors ranging from genetics and lifestyle to the newly appreciated role of our gut microbiome. Among the molecules produced by gut bacteria, trimethylamine-N-oxide (TMAO) has emerged as a significant player in cardiovascular health.
TMAO is produced when gut bacteria break down certain nutrients in food, particularly choline, lecithin, and carnitine, which are abundant in red meat and eggs. High levels of TMAO in the blood have been linked to an increased risk of atherosclerosis, a condition where plaque builds up inside the arteries, leading to heart attacks and strokes.
Now, a new study published in Advances in Medical Sciences sheds light on how TMAO might exert its harmful effects at a cellular level. Researchers focused on macrophages, a type of immune cell that plays a critical role in the development of atherosclerosis. The study reveals that TMAO can induce stress within these cells, potentially exacerbating the disease process.
TMAO and Cardiovascular Risk
TMAO is a gut microbiota-derived metabolite formed from dietary precursors and has been linked to atherosclerosis. A 2023 review reports that TMAO contributes directly to atherosclerosis pathogenesis, with toll-like receptors TLR2 and TLR4 involved in processes related to plaque stability. Recent studies, including work using the longitudinal Multi-Ethnic Study of Atherosclerosis, have examined TMAO in relation to cardiovascular outcomes. Research in predominantly Asian stroke populations has also identified TMAO as a potential blood biomarker for predicting incident stroke and major adverse cardiovascular events.
Measuring TMAO Reliably
Liquid chromatography-tandem mass spectrometry, or LC-MS/MS, is described as a sensitive and specific approach for quantifying TMAO. One 2021 method measures TMAO, carnitine, betaine, and choline simultaneously without isotope-labeled standards, while another validated method uses calibration curves in a surrogate matrix instead of human plasma. These methods are intended to improve speed, accuracy, and clinical applicability. A 2025 report describes an HPLC-MS/MS method with high reproducibility for assessing plasma TMAO in people with subclinical atherosclerosis, while emphasizing the importance of standardized data.
From Gut Metabolite to Risk Factor
Research on TMAO has focused on how gut microbes generate trimethylamine, how enzymes convert it to TMAO, and how these processes may promote atherosclerosis. A 2018 review describes atherosclerosis as the primary cause of heart disease and stroke and reports that blood TMAO had been identified as an independent cardiovascular disease risk factor in humans. The same research direction has examined vascular inflammation and the accumulation of lipids and fibrous elements in arteries. More recent work reports that elevated TMAO is associated with atherosclerosis and thrombotic disorders, while continuing to investigate its molecular basis.
TMAO's Impact on Macrophages: What the Study Revealed
The researchers at Kerman University of Medical Sciences, Iran, investigated the effects of TMAO on J774A.1 murine macrophages, a commonly used cell line in research. They exposed these cells to varying concentrations of TMAO and then examined the expression of two key proteins: GRP94 and HSP70. These proteins are known as heat shock proteins, which are produced by cells under stress to help them survive.
- GRP94 Increase: TMAO exposure led to a notable increase in GRP94 protein levels. GRP94, found in the endoplasmic reticulum (ER), is crucial for protein folding and quality control. Elevated GRP94 typically signals ER stress, indicating cellular disruption.
- HSP70 Activation: Higher doses of TMAO significantly boosted HSP70 levels, particularly after longer exposure. HSP70 helps stabilize proteins and prevent damage from stressors, confirming TMAO's role in inducing cellular stress.
- PBA Ineffectiveness: 4-phenylbutyric acid (PBA), a chemical chaperone known to reduce ER stress, did not alter GRP94 or HSP70 levels, suggesting that TMAO's effects might involve distinct stress pathways.
- Comparison with Tunicamycin: Tunicamycin, a potent ER stress inducer, greatly increased GRP94 levels, establishing a benchmark for TMAO's stress-inducing capability.
TMAO and Cellular Stress
Recent reviews describe TMAO as a possible link between the gut microbiota and cardiovascular disease, based on findings from cell and animal models and associations with cardiovascular risk and outcomes. In mouse macrophages, TMAO has been reported to induce stress-inducible heat shock proteins, including glucose-regulated protein 94 and HSP70, leading to endoplasmic reticulum stress. Other studies report abnormal macrophage activation alongside increased expression of glucose-regulated protein 78 and HSP60. These findings support cellular stress as a proposed mechanism, although they do not by themselves establish causation in humans.
Association Is Not Proof
The evidence connecting TMAO with cardiovascular disease remains complicated by the disease's interactions among atherosclerosis, inflammation, metabolic dysregulation, and the gut and oral microbiomes. A 2025 systematic review describes microbiome metabolism of dietary precursors into trimethylamine and the liver's conversion of trimethylamine into TMAO as potentially important contributors to cardiovascular disease. Separately, a Multi-Ethnic Study of Atherosclerosis analysis examined serial plasma TMAO measurements and their association with all-cause and cause-specific mortality during long-term follow-up. These findings describe associations and biological pathways, but they do not alone prove that TMAO causes cardiovascular events or mortality.
What Does This Mean for Your Heart Health?
This research provides a deeper understanding of how TMAO contributes to heart disease. By inducing stress in macrophages, TMAO may promote the formation of foam cells, a key component of atherosclerotic plaques. While further research is needed, these findings highlight the potential benefits of strategies aimed at reducing TMAO levels or mitigating its effects on immune cells. This includes dietary changes, such as reducing red meat and egg consumption, and exploring novel therapies that target the gut microbiome.
A Promising but Unsettled Biomarker
TMAO is described as a diet-induced metabolite produced by the gut microbiota and mainly eliminated through renal excretion. The cited review reports correlations between higher TMAO and atherosclerotic cardiovascular disease, cardiovascular mortality, and major adverse cardiovascular events. It also notes that meta-analyses have proposed an association between high TMAO and adverse cardiovascular outcomes. Taken together, these findings make TMAO a promising biomarker and mechanistic candidate, while the evidence presented remains primarily correlational.